1. Home
  2. FIGS vs VKTX Comparison

FIGS vs VKTX Comparison

Compare FIGS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FIGS Inc.

FIGS

FIGS Inc.

N/A

Current Price

$19.76

Market Cap

3.2B

ML Signal

N/A

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$26.97

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FIGS
VKTX
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
FIGS
VKTX
Price
$19.76
$26.97
Analyst Decision
Buy
Strong Buy
Analyst Count
9
21
Target Price
$21.13
★ $95.32
AVG Volume (30 Days)
4.5M
★ 4.6M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 850.00
N/A
EPS
★ 0.28
N/A
Revenue
★ $419,591,000.00
N/A
Revenue This Year
$20.59
N/A
Revenue Next Year
$9.43
N/A
P/E Ratio
$121.89
★ N/A
Revenue Growth
★ 59.47
N/A
52 Week Low
$8.36
$23.82
52 Week High
$22.46
$43.15

Technical Indicators

Market Signals
Indicator
FIGS
VKTX
Relative Strength Index (RSI) 55.02 47.92
Support Level $13.37 $26.47
Resistance Level N/A $34.00
Average True Range (ATR) 1.10 1.58
MACD -0.24 0.37
Stochastic Oscillator 8.20 73.44

Price Performance

Historical Comparison
FIGS
VKTX

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: